Checkpoint inhibitor

This page covers all Checkpoint inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD47, PD-1.

Targets

CD47 · PD-1

Phase 2 pipeline (2)

• M-CENK · ImmunityBio, Inc. · Oncology
  M-CENK is a cancer immunotherapy that targets the CD47/SIRPα axis.
• Anti-PD-1 Checkpoint Inhibitor · Istari Oncology, Inc. · Oncology
  Inhibits PD-1 receptor